TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
HIMS

Hims Hers Health Inc

Healthcare · Drug Manufacturers - Specialty & Generic

28.40$ -6.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HIMS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
+51.6% +64.7% +254.3% -12.9% +20.4% +60.4% +204.5%
+47.0% +62.5% +138.7% -19.8% +22.4% +49.3% +93.9%
-45.4% +20.7% +162.5% -34.8% +106.7% +128.2% +3.6%
+45.5% +66.0% +146.8% -27.4% +23.0% +35.9% +92.3%
+72.1% -12.7% +376.9% -9.7% +108.9% -9.9% +428.8%
+14.1% -16.0% +282.7% +59.0% +4.2% +186.8% +79.6%
+750.0% +200.6% +55.3%
+0.0% +0.0% +1.7% +146.9%
-95.5% +43,781.4% -15.6% -15.0% +133.7% +351.8%
+738.5% +28.1% -67.6% -36.5% +77.9% +137.6% +599.1%
-14.5% -26.2% +420.2% -39.5% +84.5% +150.2% +82.7%
-80.5% +185.1% -68.4% +21.5% -22.7% +47.5% +156.4%
-45.7% +11.5% +143.5% +64.8% +33.1% +111.7% +57.1%
-693.5% -6.8% +10.4% +38.6% +13.5%
-48.3% +1.7% +428.3% +9.5% +2.4% +13.1% +9.0%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?